- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Del Global reconciles with shareholders
Trying to settle a lawsuit initiated in November after accounting irregularities were uncovered, Del Global has reached a tentative deal with shareholders. Under the agreement, Del will contribute $2 million in a subordinated note due in five years with
Trying to settle a lawsuit initiated in November after accounting irregularities were uncovered, Del Global has reached a tentative deal with shareholders. Under the agreement, Del will contribute $2 million in a subordinated note due in five years with interest at 6% per annum, 2.5 million shares of Del stock, and warrants to purchase one million shares exercisable at $2.00 per share, expiring in six years. The plaintiffs will also receive a $2 million cash payment to which Del will not contribute. The courts must yet approve the deal. In a separate action, Samuel E. Park has been appointed president and CEO of Del. Park has acted in this capacity since February.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
